Search the Newsreel

The 5 Most Interesting Analyst Questions From Meritage Homes’s Q2 Earnings Call

Proposed MMSI (MMSI) insider stock sale disclosed in Form 144 filing

A Form 144 filing indicates a proposed sale of up to 21,449 shares of Merit Medical Systems Inc. (MMSI) common stock by an affiliate. The shares, consisting of Performance Shares and Restricted Stock granted in 2025 and 2026, are expected to be sold on …

Merit Medical Systems (MMSI) Stock Looks Undervalued On Cash Flow But Overvalued On Earnings

Meritage Homes (NYSE:MTH) Issues Quarterly Earnings Results, Beats Estimates By $0.13 EPS

Meritage Homes (NYSE:MTH) announced quarterly earnings of $1.42 per share, surpassing analyst estimates of $1.29 by $0.13. Despite beating EPS, the company's revenue of $1.41 billion fell slightly short of the $1.43 billion forecast. Following the announcement, Meritage Homes' shares decreased by 2.4% to …

Meritage Homes Market Sentiment

This article analyzes the market sentiment for Meritage Homes (MTH) based on analyst consensus, short interest, options flow, and insider activity. It highlights a "Neutral" analyst consensus with an average price target of $92 and notes a rising short interest of 8.0%. The article …

Meritage Homes CORP 2026: Revenue $91.81M, EPS $1.37— 10-Q Summary

Meritage Homes CORP (MTH) reported Q2 2026 results with revenue of $91.81 million and diluted EPS of $1.37, showing a decline compared to the prior-year quarter due to softer demand and lower average selling prices. Home closings and revenue decreased, while the company focused …

Meritage Homes Earnings Call: Resilience Amid Margin Strain

Meritage Homes reported solid execution in Q2 2026 despite pressures from weaker demand and lower margins, emphasizing cost control, faster build cycles, and a strong balance sheet. The company generated $1.4 billion in home closing revenue, though GAAP diluted EPS fell by about 33%. …

The Manufacturers Life Insurance Company Purchases 148,703 Shares of Merit Medical Systems, Inc. $MMSI

Merit Medical (MMSI) Stock Eyes Bigger Growth Run After Profit Outlook Lift

MERIT MEDICAL SYSTEMS INC : NEEDHAM RAISES TARGET PRICE TO $101 FROM $90

Needham has increased its target price for Merit Medical Systems Inc (MMSI.O) from $90 to $101. This update reflects a positive revision in the analyst's outlook for the company. The news was reported by Reuters.

Merit Medical Systems, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MMSI) 2026-07-31

Merit Medical Systems, Inc. (MMSI) released its Q2 2026 earnings call presentation, reporting an EPS of $1.19, which beat estimates by $0.23. The company also reported revenues of $418.84 million, a 9.51% year-over-year increase, beating estimates by $13.50 million. This slide deck accompanies their …

Merit Medical Systems, Inc. Stock 12‑Month Price Target Raised to $99.82, Implies 20% Upside

Merit Medical Systems, Inc.'s average 12-month price target has been increased to $99.82 from $90.09, based on estimates from 11 analysts. This updated target suggests a potential upside of approximately 20% from the July 30 closing price. The consensus rating for MMSI stock remains …

MERIT MEDICAL SYSTEMS, INC. : WELLS FARGO RAISES TARGET PRICE TO $83 FROM $74

Wells Fargo has increased its target price for MERIT MEDICAL SYSTEMS, INC. (MMSI.O) to $83 from $74. This update was reported by Reuters on July 31, 2026. The article states that the content reflects the author's opinion and is not investment advice.

Merit Medical Systems Q2 Non-GAAP Earnings, Net Sales Rise; Lifts 2026 Guidance

Merit Medical Systems reported increased non-GAAP earnings and net sales for Q2, leading the company to raise its financial guidance for 2026. This positive performance indicates strong operational results and an optimistic outlook for the coming year.

Merit Medical: Q2 Earnings Snapshot

This article provides a brief snapshot of Merit Medical's Q2 earnings. Due to the lack of detailed financial information, specific figures or performance metrics cannot be reported in the summary.

Canaccord raises Merit Medical stock price target on strong Q2 results

Canaccord increased its price target for Merit Medical Systems (NASDAQ:MMSI) to $94 from $85, maintaining a Buy rating after the company reported strong second-quarter results. Merit Medical surpassed revenue and EPS estimates, showing 10% year-over-year revenue growth and its strongest organic growth in three …

MTH Q2 Deep Dive: Margin Discipline and Strategic Product Shift Amid Soft Demand

MTH Q2 Deep Dive: Margin Discipline and Strategic Product Shift Amid Soft Demand Homebuilder Meritage Homes (NYSE:MTH) missed Wall Street's revenue expectations in Q2 CY2026, with sales falling 13.8% year on year to $1.41 billion. Its non-GAAP profit of $1.42 per share was 9.2% …

Meritage Homes Corp (MTH) (Q2 2026) Earnings Call Highlights: Strong Operational Execution Amid ...

This article first appeared on GuruFocus. Release Date: July 30, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Meritage Homes Corp (NYSE:MTH) achieved a 200% backlog conversion rate in Q2 2026, reflecting strong …

Merit Medical Systems (NASDAQ:MMSI) Announces Quarterly Earnings Results, Beats Expectations By $0.23 EPS

Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance

Merit Medical Systems, Inc. announced strong financial results for the second quarter of 2026, surpassing expectations with a 9% organic, constant currency revenue growth. The company reported a 10% increase in U.S. sales and improved non-GAAP operating margin and EPS. Reflecting these robust results, …

Earnings call transcript: Merit Medical tops Q2 2026 estimates and lifts outlook

Merit Medical Systems reported strong Q2 2026 results, exceeding Wall Street expectations for profit and sales with adjusted earnings of $1.19 per share and revenue of $418.8 million. The company also raised its full-year outlook, citing its strongest organic growth in three years and …

Merit Medical posts Q2 beat, raises FY26 EPS and sales guidance

Merit Medical Systems exceeded its Q2 2026 expectations with $418.8 million in revenue, a 10% increase year-over-year, and non-GAAP EPS of $1.19, up 18%. This strong performance, driven by robust U.S. demand and margin expansion, led the company to raise its full-year 2026 adjusted …

Meritage outlines Q3 2026 EPS of $1.10-$1.30 while upping full-year closings and revenue outlook to ~5% below 2025

Earnings Call Insights: Meritage Homes (MTH) Q2 2026 MANAGEMENT VIEW * "Consistent with what others have shared about the spring selling season, we also experienced slower-than-normal selling conditions, driving quarterly sales orders of 3,575, which were 9% below prior year." (Executive Chairman Steven Hilton) …

Merit Medical Systems (NASDAQ:MMSI) Jumps After Q2 Earnings Beat and Revenue Slightly Ahead of Estimates

Merit Medical Systems (NASDAQ:MMSI) reported strong second-quarter 2026 results, with non-GAAP EPS of $1.19 significantly beating analyst estimates of $0.9782 and revenue of $418.8 million slightly exceeding projections. This performance, driven by strength in cardiovascular and endoscopy segments, led to a positive market reaction …

Meritage Q2 2026 earnings telegraph move-up buyer pivot

Meritage Homes' Q2 2026 earnings surpassed expectations, but the company's long-term strategy reveals a significant pivot towards first-time move-up buyers, anticipating a materially different market due to enduring affordability challenges for entry-level buyers. This shift suggests that Meritage views these challenges as structural rather …

(MMSI) Merit Medical Systems Now Expects Full Year 2026 Adjusted EPS Range $4.25 - $4.35, vs. FactSet Est of $4.07

Merit Medical Systems (MMSI) has updated its guidance for the full year 2026, now expecting adjusted EPS to be in the range of $4.25 - $4.35. This revised forecast is notably higher than the FactSet estimate of $4.07. The company had also previously announced …

Merit Medical Systems (NASDAQ: MMSI) Q2 earnings rise on margin gains

Merit Medical Systems reported a strong Q2 2026, with net sales increasing by 9.5% to $418.8 million and net income rising to $38.8 million, or $0.65 diluted EPS, driven by improved gross profit margins. The company's foundational and therapeutic product categories both saw significant …

Merit Medical reports $418.8M revenue and 9% organic growth

Merit Medical (NASDAQ: MMSI) reported strong second-quarter 2026 financial results, with revenue up 10% to $418.8 million and organic growth of 9%. The company also raised its full-year 2026 revenue guidance to $1.631–$1.643 billion and non-GAAP EPS guidance to $4.25–$4.35, reflecting confidence in continued …

Homebuilder Meritage Homes updates 2026 outlook to ~5% below 2025

Meritage Homes (NYSE:MTH) reported a challenging Q2 2026 with a 14% year-over-year decline in home closing revenue to $1.39 billion and a 33% drop in diluted EPS to $1.37. The company attributed this performance to macroeconomic uncertainty and volatile interest rates affecting buyer psychology. …

Merit Medical Systems (NASDAQ:MMSI) Updates FY 2026 Earnings Guidance

Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Meritage Homes Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:MTH) 2026-07-30

Meritage Homes Q2 Earnings, Revenue Decline

The provided content is empty and contains no information about Meritage Homes' Q2 earnings or revenue. Therefore, a summary cannot be generated.

Meritage Homes Corp (MTH) Institutional Confidence

Meritage Homes Corp (MTH) has an institutional shareholding score of 10.00, ranking 1st in its industry. The institutional shareholding proportion increased by 14.21% quarter-over-quarter, with the largest shareholder being ETHSX. Several other major institutional investors also show significant holdings and changes in MTH shares.

Compared to Estimates, Meritage (MTH) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Meritage Homes (MTH) reported revenue of $1.4 billion, down 13.8% over the same period last year. EPS came in at $1.42, compared to $2.04 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …